Up­dat­ed: Take­da to re­vamp in mul­ti­year quest, piv­ots CAR-NK ther­a­py from can­cer to au­toim­mune

Take­da is launch­ing a broad, mul­ti­year re­struc­tur­ing, along­side a hand­ful of pipeline cuts, CEO Christophe We­ber an­nounced Thurs­day.

Start­ing this year, Take­da

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER